| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |